Why Choose Private Prescription For Weight Management?
Private Wegovy To Mounjaro Conversion Assessment UK
When creating a wegovy to mounjaro conversion chart for private prescription patients, the key difference lies in mechanism of action rather than direct dose equivalency. Wegovy contains semaglutide, a single GLP-1 receptor agonist, while Mounjaro utilises tirzepatide, a dual GIP and GLP-1 receptor agonist. This fundamental distinction means there's no straightforward milligram-to-milligram conversion between the treatments. Instead, both medications follow their own specific dose escalation schedules designed to minimise side effects whilst maximising efficacy.
Private prescription patients benefit from personalised prescriber guidance when transitioning between treatments, something often unavailable through stretched NHS services. Your EverydayMeds prescriber can review your current Wegovy dose, assess your response and tolerance, then recommend the appropriate Mounjaro starting dose – typically beginning with the standard 2.5mg initiation regardless of your previous Wegovy strength. This individualised approach ensures optimal treatment outcomes without the lengthy specialist referral delays common in NHS weight management pathways.
Private Prescription Pricing For Wegovy To Mounjaro Chart Comparison
Understanding the wegovy to mounjaro conversion chart extends beyond clinical considerations to include cost analysis for private patients. Wegovy pricing starts at £79.99 for the 0.25mg starter dose (with FIRST40 applied at checkout), progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the maintenance 2.4mg dose. Our bundle options provide convenience for long-term treatment, such as the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99, supporting your initial 12-week escalation period.
Mounjaro follows its own pricing structure, allowing direct cost comparison when planning your wegovy to mounjaro conversion journey. Returning customers benefit from code DOSE25 at checkout, whilst new patients use FIRST40 for optimal pricing. Both treatments require the same rigorous clinical assessment process, ensuring you receive appropriate medical oversight regardless of your chosen prescription-only medicine. This transparency helps private patients budget effectively for their weight management journey without NHS funding uncertainties.
Clinical Evidence Behind Wegovy To Mounjaro Conversion Decisions
The wegovy to mounjaro conversion chart consideration involves understanding each treatment's clinical evidence base. Wegovy's efficacy stems from the STEP trial programme, with STEP 1 demonstrating approximately 15% average weight loss at 68 weeks when used alongside diet and exercise (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial further showed a 20% reduction in major cardiovascular events, supporting Wegovy's role beyond weight management.
Mounjaro's evidence comes from the SURMOUNT trials, showing its dual-agonist mechanism may offer different benefits for certain patients. When consulting your wegovy to mounjaro conversion chart, prescribers consider these distinct evidence profiles alongside your individual response patterns, medical history, and treatment goals to recommend the most suitable option.
How Wegovy Works In Your Conversion Assessment
Before completing any wegovy to mounjaro conversion chart evaluation, understanding Wegovy's mechanism proves crucial for informed decision-making. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormones responsible for appetite regulation. This prescription-only medicine works by binding to GLP-1 receptors in your brain's appetite centres, promoting feelings of fullness after smaller meals whilst reducing food cravings between eating occasions. The once-weekly injection provides sustained hormone activity, helping maintain consistent appetite suppression throughout your treatment period. Additionally, Wegovy may slow gastric emptying, contributing to prolonged satiety and supporting portion control efforts when combined with your reduced-calorie diet and increased physical activity programme.
Streamlined Private Prescription Ordering Process
Accessing your wegovy to mounjaro conversion chart consultation through EverydayMeds eliminates traditional NHS barriers that delay treatment initiation. Our 3-minute online clinical assessment captures essential medical history, current medications, and treatment goals without requiring GP referral letters or specialist appointment scheduling. Once submitted, our prescribers review your assessment within 3 working days (or 24 hours with express service), providing personalised recommendations for your conversion journey. Upon approval, both Wegovy and Mounjaro ship via next-day delivery using temperature-controlled cold-chain logistics, ensuring medication integrity from our GPhC-registered pharmacy (#9012878) directly to your door. This efficient process transforms what could be a 6+ month NHS wait into a matter of days, enabling prompt treatment commencement.
Storage Advantages When Planning Your Conversion Chart
Practical considerations within your wegovy to mounjaro conversion chart include storage requirements that may influence treatment preference. Wegovy offers superior storage flexibility with 6 weeks room temperature stability once removed from refrigeration (below 30°C), compared to Mounjaro's 21-day room temperature limit. Both treatments require initial refrigerated storage at 2-8°C, but Wegovy's extended room temperature window proves advantageous for frequent travellers or those with limited fridge space. The FlexTouch pen delivery system provides consistent dosing accuracy throughout both treatments' escalation schedules. Whether maintaining your current Wegovy regimen or transitioning to Mounjaro, proper storage ensures optimal medication potency and treatment effectiveness. This practical advantage often factors into conversion decisions for patients with active lifestyles or irregular schedules.
Personalised Conversion Planning For UK Private Patients
Creating an effective wegovy to mounjaro conversion chart requires understanding that private prescription patients have unique advantages over NHS counterparts. Private patients can access both treatments simultaneously during transition periods, enabling gradual changeover under prescriber guidance rather than abrupt switching common in resource-limited NHS settings. Your prescriber can recommend optimal timing for conversion based on your current Wegovy response, side effect profile, and individual circumstances. This personalised approach may involve completing your current Wegovy pen before initiating Mounjaro, or coordinating timing around holidays, work commitments, or other life events.
Furthermore, private prescription enables access to both treatments' full dose ranges without formulary restrictions that sometimes limit NHS availability. Your wegovy to mounjaro conversion chart consultation includes ongoing support, with prescribers available for questions or concerns throughout your transition period. This continuity of care, combined with assured medication supply, provides peace of mind unavailable through NHS services where stock shortages or funding changes can disrupt treatment unexpectedly.
Expert Guidance For Your Treatment Journey
Making informed decisions about your wegovy to mounjaro conversion chart requires expert medical guidance tailored to your individual circumstances. At EverydayMeds, our clinical team understands that both treatments represent significant commitments requiring careful consideration of efficacy, tolerability, and lifestyle factors. New patients can use code FIRST40 at checkout to access competitive pricing, whilst returning customers benefit from DOSE25 for continued value. Our GPhC-registered pharmacy ensures both treatments meet identical quality standards, whether you continue with Wegovy or transition to Mounjaro based on your prescriber's recommendations. Remember that weight management represents a long-term journey requiring ongoing medical support, and both treatments work most effectively alongside sustainable dietary changes and regular physical activity. Contact our clinical team today to discuss your personalised wegovy to mounjaro conversion chart and take the next step in your weight management journey with confidence.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
